Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression
Clinical trial NCT07655622 · RECRUITING
Trial details
- NCT number
- NCT07655622
- Sponsor
- Second Affiliated Hospital of Nanchang University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-03
- Primary completion
- 2027-12-03
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.